Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:30 pm Purchase | 2025-09-30 | 13G | Peabody Energy Corporation BTU | Maverick Capital, Ltd. | 8,157,413 6.700% | 1,509,583 (+22.71%) | Filing History |
| 2025-11-14 4:30 pm Sale | 2025-09-30 | 13G | Curis, Inc. CRIS | Maverick Capital, Ltd. | 49,554 0.400% | -631,827 (-92.73%) | Filing History |
| 2025-11-14 4:30 pm Unchanged | 2025-09-30 | 13G | Fractyl Health, Inc. Common Stock GUTS | Maverick Capital, Ltd. | 4,248,492 3.100% | 0 (Unchanged) | Filing History |
| 2025-09-26 4:30 pm Purchase | 2025-09-19 | 13G | Peabody Energy Corporation BTU | Maverick Capital, Ltd. | 6,647,830 5.500% | 6,647,830 (New Position) | Filing History |
| 2025-08-14 08:00 am Sale | 2025-06-30 | 13G | Invivyd, Inc. IVVD | Maverick Capital, Ltd. | 10,229,118 8.500% | -1,536,669 (-13.06%) | Filing History |
| 2025-08-14 08:00 am Purchase | 2025-06-30 | 13G | Rocket Pharmaceuticals, Inc. RCKT | Maverick Capital, Ltd. | 8,363,813 7.800% | 2,816,638 (+50.78%) | Filing History |
| 2025-04-14 5:10 pm Purchase | 2025-04-07 | 13G | Rocket Pharmaceuticals, Inc. RCKT | Maverick Capital, Ltd. | 5,547,175 5.200% | 5,547,175 (New Position) | Filing History |
| 2025-02-14 4:15 pm Sale | 2024-12-31 | 13G | Wave Life Sciences Ltd. WVE | Maverick Capital, Ltd. | 8,261,242 5.400% | -186,562 (-2.21%) | Filing History |
| 2025-02-14 4:15 pm Sale | 2024-12-31 | 13G | Verona Pharma plc VRNA | Maverick Capital, Ltd. | 25,028,128 3.800% | -8,699,656 (-25.79%) | Filing History |
| 2025-02-14 4:15 pm Purchase | 2024-12-31 | 13G | Curis, Inc. CRIS | Maverick Capital, Ltd. | 681,381 8.000% | 99,108 (+17.02%) | Filing History |
| 2024-11-14 4:31 pm Purchase | 2024-09-30 | 13G | Verona Pharma plc VRNA | Maverick Capital, Ltd. | 33,727,784 5.200% | 33,727,784 (New Position) | Filing History |
| 2024-11-14 4:30 pm Purchase | 2024-09-30 | 13G | Invivyd, Inc. IVVD | Maverick Capital, Ltd. | 11,765,787 9.900% | 2,421,838 (+25.92%) | Filing History |
| 2024-11-14 4:30 pm Purchase | 2024-09-30 | 13G | Fractyl Health, Inc. Common Stock GUTS | Maverick Capital, Ltd. | 4,248,492 8.900% | 4,248,492 (New Position) | Filing History |
| 2024-02-14 5:12 pm Purchase | 2023-12-31 | 13G | Invivyd, Inc. IVVD | Maverick Capital, Ltd. | 9,343,949 8.500% | 9,343,949 (New Position) | Filing History |
| 2024-02-14 5:03 pm Sale | 2023-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | Maverick Capital, Ltd. | 0 0.000% | -251,641 (Position Closed) | Filing History |
| 2024-02-14 5:02 pm Purchase | 2023-12-31 | 13G | Wave Life Sciences Ltd. WVE | Maverick Capital, Ltd. | 8,447,804 6.900% | 1,350,140 (+19.02%) | Filing History |
| 2024-02-14 5:01 pm Unchanged | 2023-11-27 | 13D | Global Technology Acquisition Corp. I GTAC | Maverick Capital, Ltd. | 1,200,000 35.400% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:58 pm Purchase | 2023-12-31 | 13G | Curis, Inc. CRIS | Maverick Capital, Ltd. | 582,273 9.900% | 582,273 (New Position) | Filing History |
| 2023-05-23 5:23 pm Unchanged | 2023-04-20 | 13D | Global Technology Acquisition Corp. I GTAC | Maverick Capital, Ltd. | 1,200,000 57.400% | 0 (Unchanged) | Filing History |
| 2023-02-14 11:57 am Sale | 2022-12-31 | 13G | Population Health Investment Co., Inc. PHIC | Maverick Capital, Ltd. | 0 0.000% | -1,185,260 (Position Closed) | Filing History |